CCDC112 Antikörper (AA 201-446) (FITC)
-
- Target Alle CCDC112 Antikörper anzeigen
- CCDC112 (Coiled-Coil Domain Containing 112 (CCDC112))
-
Bindungsspezifität
- AA 201-446
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CCDC112 Antikörper ist konjugiert mit FITC
- Applikation
- Bitte anfragen
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Coiled-coil domain-containing protein 112 protein (201-446AA)
- Isotyp
- IgG
- Top Product
- Discover our top product CCDC112 Primärantikörper
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- CCDC112 (Coiled-Coil Domain Containing 112 (CCDC112))
- Andere Bezeichnung
- CCDC112 (CCDC112 Produkte)
- Synonyme
- CCDC112 antikoerper, RGD1561942 antikoerper, MBC1 antikoerper, 8430438M01Rik antikoerper, AW108467 antikoerper, coiled-coil domain containing 112 antikoerper, CCDC112 antikoerper, Ccdc112 antikoerper, ccdc112 antikoerper
- Hintergrund
- MBC1 antibody, CC112_HUMAN antibody, CCDC112 antibody, coiled coil domain containing 112 antibody, Coiled coil domain containing protein 112 antibody, Coiled-coil domain-containing protein 112 antibody, Mutated in bladder cancer 1 antibody, Mutated in bladder cancer protein 1 antibody
- UniProt
- Q8NEF3
-